Cargando…
An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancer
BACKGROUND: Women undergoing treatment for breast cancer require frequent clinic visits for maintenance of therapy. With COVID-19 causing health care disruptions, it is important to learn about how this population’s access to health care has changed. This study compares self-reported health care uti...
Autores principales: | Paladino, Andrew J., Pebley, Kinsey, Kocak, Mehmet, Krukowski, Rebecca A., Waters, Teresa M., Vidal, Gregory, Schwartzberg, Lee S., Curry, Andrea N., Graetz, Ilana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684812/ https://www.ncbi.nlm.nih.gov/pubmed/36419005 http://dx.doi.org/10.1186/s12913-022-08705-9 |
Ejemplares similares
-
THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer
por: Paladino, Andrew J., et al.
Publicado: (2019) -
Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer Before Starting Chemotherapy
por: Hu, Xin, et al.
Publicado: (2021) -
THRIVE intervention development: using participatory action research principles to guide a mHealth app-based intervention to improve oncology care
por: Anderson, Janeane N., et al.
Publicado: (2021) -
Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer
por: Hu, Xin, et al.
Publicado: (2022) -
Mobile application to support oncology patients during treatment on patient outcomes: Evidence from a randomized controlled trial
por: Graetz, Ilana, et al.
Publicado: (2022)